Preparation of tributyrin emulsion and characterization of the binding of the emulsion particles to low-density lipoprotein in vitro

Journal of Pharmaceutical Sciences

Volumn 93, Issue 7, 2004, Pages 1755-1765

  Su, Jie ^a   Ho, Paul C ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Emulsion; Interaction; Lipoprotein; Phospholipid; Tributyrin

Indexed keywords

ANTINEOPLASTIC AGENT; CHOLESTEROL; CHOLESTEROL OLEATE; LIPOID E80; LOW DENSITY LIPOPROTEIN; PHOSPHATIDYLCHOLINE; TRIBUTYRIN;

ARTICLE; BINDING AFFINITY; DISSOCIATION CONSTANT; DRUG DELIVERY SYSTEM; DRUG PROTEIN BINDING; DRUG SYNTHESIS; EMULSION; PARTICLE SIZE; ULTRACENTRIFUGATION; ULTRASOUND;

EID: 3042548986     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.20092     Document Type: Article

References (52)

1. Parlo RA, Coleman PS. 1984. Enhanced rate of citrate export from cholesterol-rich hepatoma mitochondria. The truncated Krebs cycle and other metabolic ramifications of mitochondrial membrane cholesterol. J Biol Chem 259:9997-10003.
2. Ho YK, Smith GL, Brown MS, Goldstein JL. 1978. Low-density lipoprotein (LDL) receptor activity in human acute myelogenous leukemia cells. Blood 52:1099-1114.
3. Firestone RA. 1994. Low-density lipoprotein as a vehicle for targeting antitumor compounds to cancer cells. Bioconjug Chem 5:105-113.
4. Leppälä J, Kallio M, Nikula T, Nikkinen P, Liewendahl K, Jääskeläinen J, Savolainen S, Gylling H, Hiltunen J, Callaway J, Kahl S, Färkkilä M. 1995. Accumulation of 99mTc-low-density lipoprotein in human malignant glioma. Br J Cancer 71:383-387.
5. Henriksson P, Ericsson S, Stege R, Ericsson M, Rudling M, Berglund L, Angelin B. 1989. Hypocholesterolaemia and increased elimination of low-density lipoproteins in metastatic cancer of the prostate. Lancet 2:1178-1180.
6. Ueyama Y, Matsuzawa U, Yamashita S, Funahashi T, Sakai N, Nakamura T, Kubo M, Tarui S. 1990. Hypocholesterolemic factor from gallbladder cancer cells. Lancet 336:707-708.
7. Gueddari N, Favre G, Hachem H, Marek E, Le Gaillard F, Soula G. 1993. Evidence for upregulated low density lipoprotein receptor in human lung adenocarcinoma cell line A549. Biochimie 75:811-819.
8. Maletinska L, Blakely EA, Bjornstad KA, Deen DF, Knoff LJ, Forte TM. 2000. Human glioblastoma cell lines: Levels of low-density lipoprotein receptor and low-density lipoprotein receptor-related protein. Cancer Res 60:2300-2303.
9. Spady DK. 1991. Lipoproteins in biological fluids and compartments: Synthesis, interconversions, and catabolism. In: Shaw JM, editor. Lipoproteins as carriers of pharmacological agents. New York: Marcel Dekker, pp 1-44.
10. Knott TJ, Pease RJ, Powell LM, Wallis SC, Rall SC Jr, Innerarity TL, Blackhart B, Taylor WH, Marcel Y, Milne R, Johnson D, Fuller M, Lusis AJ, McCarthy BJ, Mahley RW, Levy-Wilson B, Scott J. 1986. Complete protein sequence and identification of structural domains of human apolipoprotein B. Nature 323:734-738.
11. Brown MS, Goldstein JL. 1986. A receptor-mediated pathway for cholesterol homeostasis. Science 232:34-47.
12. Chanson NF, Lontie JFO, Gulik A, Férézou J, Carpentier YA. 2002. LDL binding to lipid emulsion particles: Effects of incubation duration, temperature, and addition of plasma subfractions. Lipids 37:573-580.
13. Maranhão RC, Garicochea B, Silva EL, Llacer PD, Cadena SMS, Coelho IC, Meneghetti JC, Pileggi FJC, Chamone DAF. 1994. Plasma kinetics and biodistribution of a lipid emulsion resembling low-density lipoprotein in patients with acute leukemia. Cancer Res 54:4660-4666.
14. Maranhãpo RC, Cesar TB, Pedroso-Mariani SR, Hirata MH, Mesquita CH. 1993. Metabolic behavior in rats of a nonprotein microemulsion resembling low density lipoprotein. Lipids 28:691-696.
15. Maranhão RC, Roland IA, Toffoletto O, Ramires JA, Gonçalves RP, Mesquita CH, Pileggi P. 1997. Plasma kinetic behavior in hyperlipidemic subjects of a lipidic microemulsion that binds to LDL receptors. Lipids 32:627-633.
16. Rodrigues DG, Covolan CC, Coradi ST, Barboza R, Maranhao RC. 2002. Use of a cholesterol-rich emulsion that binds to low-density lipoprotein receptors as a vehicle for paclitaxel. J Pharm Pharmacol 54:765-772.
17. Maranhão RC, Graziani SR, Yamaguchi N, Melo RF, Latrilha MC, Rodrigues DG, Couto RD, Schreier S, Buzaid AC. 2002. Association of carmustine with a lipid emulsion: In vitro, in vivo and preliminary studies in cancer patients. Cancer Chemother Pharmacol 49:487-498.
18. Planchon P, Pouillart P, Ronco G, Villa P, Pieri F. 1993. Differential elimination of synthetic butyric triglycerides in vivo: A pharmacokinetic study. J Pharm Sci 82:1046-1048.
19. Conley BA, Egorin MJ, Tait N, Rosen DM, Sausville EA, Dover G, Fram RJ, Van Echo DA. 1998. Phase I study of the orally administered butyrate prodrug, tributyrin, in patients with solid tumors. Clin Cancer Res 4:629-634.
20. Yan J, Xu YH. 2003. Tributyrin inhibits human gastric cancer SGC-7901 cell growth by inducing apoptosis and DNA synthesis arrest. World J Gastroenterol 9:660-664.
21. Schroder CP, Maurer HR. 2002. Tributyrin-induced differentiation promotes apoptosis of LS 174T colon cancer cells in vitro. Int J Oncol 20:195-200.
22. Clarke KO, Feinman R, Harrison LE. 2001. Tributyrin, an oral butyrate analogue, induces apoptosis through the activation of caspase-3. Cancer Lett 171:57-65.
23. Gaschott T, Maassen CU, Stein J. 2001. Tributyrin, a butyrate precursor, impairs growth and induces apoptosis and differentiation in pancreatic cancer cells. Anticancer Res 21:2815-2819.
24. Watkins SM, Carter LC, Mak J, Tsau J, Yamamoto S, German JB. 1999. Butyric acid and tributyrin induce apoptosis in human hepatic tumour cells. J Dairy Res 66:559-567.
25. Heerdt BG, Houston MA, Anthony GM, Augenlicht LH. 1999. Initiation of growth arrest and apoptosis of MCF-7 mammary carcinoma cells by tributyrin, a triglyceride analogue of the short-chain fatty acid butyrate, is associated with mitochondrial activity. Cancer Res 59:1584-1591.
26. Schroder CP, Eckert K, Maurer HR. 1998. Tributyrin induces growth inhibitory and differentiating effects on HT-29 colon cancer cells in vitro. Int J Oncol 13:1335-1340.
27. Gaschott T, Steinhilber D, Milovic V, Stein J. 2001. Tributyrin, a stable and rapidly absorbed prodrug of butyric acid, enhances antiproliferative effects of dihydroxycholecalciferol in human colon cancer cells. J Nutr 131:1839-1843.
28. Schroder CP, Maurer HR. 2001. Tributyrin enhances the cytotoxic activity of interleukin-2/interleukin-12 stimulated human natural killer cells against LS 174T colon cancer cells in vitro. Cancer Immunol Immunother 50:69-76.
29. Witt O, Schmejkal S, Pekrun A. 2000. Tributyrin plus all-trans-retinoic acid efficiently induces fetal hemoglobin expression in human erythroleukemia cells. Am J Hematol 64:319-321.
30. Gaschott T, Steinhilber D, Armbruster FP, Caspary WF. 2000. Enhancement of tributyrin-induced growth inhibiting and differentiating effects on Caco-2 cells by 1,25-dihydroxyvitamin D-3. Gastroenterology 118(Part 2 Suppl):4954.
31. Presti FT, Pace RJ, Chan SI. 1982. Cholesterol-phospholipid interaction in membranes. 2. Stoichiometry and molecular packing of cholesterol-rich domains. Biochemistry 21:3831-3835.
32. Deckelbaum RJ. 1987. Structure and composition of human plasma lipoproteins. In: Olsson AG, editor. Atherosclerosis: Biology and clinical science. New York: Churchill Livingstone, pp 251-255.
33. Shawer M, Greenspan P, Oie S, Lu DR. 2002. VLDL-resembling phospholipid-submicron emulsion for cholesterol-based drug targeting. J Pharm Sci 91:1405-1413.
34. Chen PS, Toribara TY Jr, Warner H. 1956. Microdetermination of phosphorus. Anal Chem 28:1756-1758.
35. Schumaker VN, Puppione DL. Sequential flotation ultracentrifugation. 1986. Methods Enzymol 128:155-170.
36. Osborne JC. 1986. Delipidation of plasma lipoproteins. Methods Enzymol 128:213-222.
37. Sata T, Havel R, Jones A. 1972. Characterization of subfractions of triglyceride-rich lipoproteins separated by gel chromatography from blood plasma of normolipemic and hyperlipemic humans. J Lipid Res 13:757-768.
38. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
39. Greenspan P, Gutman RL. 1993. Detection by Nile Red of agarose gel electrophoresed native and modified low-density lipoprotein. Electrophoresis 14:65-68.
40. Eklund A, Sjöblom L. 1986. Improved banding pattern of rat plasma lipoproteins developed by agarose gel electrophoresis at pH 7.0. Biochim Biophys Acta 877:135-140.
41. Yokoyama S, Fukushima D, Kupferberg JP, Kezdy FJ, Kaiser ET. 1980. The mechanism of activation of lecithin/cholesterol acyltransferase by apolipoprotein A-I and an amphiphilic peptide. J Biol Chem 255:7333-7339.
42. Redgrave TG, Vassiliou GG, Callow MJ. 1987. Cholesterol is necessary for triacylglycerol-phospholipid emulsions to mimic the metabolism of lipoproteins. Biochim Biophys Acta 921:154-157.
43. Bakan DA, Longino MA, Weichert JP, Counsell RE. 1996. Physicochemical characterization of a synthetic lipid emulsion for hepatocyte-selective delivery of lipophilic compounds: Application to polyiodinated triglycerides as contrast agents for computed tomography. J Pharm Sci 85:908-914.
44. Oldfield E, Meadows M, Rice D, Jacobs R. 1978. Spectroscopic studies of specifically deuterium labeled membrane systems. Nuclear magnetic resonance investigation of the effects of cholesterol in model systems. Biochemistry 17:2727-2740.
45. Trouard TP, Nevzorov AA, Alam TM, Job C, Zajicek J, Brown MF. 1999. Influence of cholesterol on dynamics of dimyristoyl-phosphatidylcholine bilayers as studied by deuterium NMR relaxation. J Chem Phys 110:8802-8818.
46. Aviram M, Keidar S, Rosenblat M, Brook GJ. 1991. Reduced uptake of cholesterol esterase-modified low density lipoprotein by macrophages. J Biol Chem 266:11567-11574.
47. Maranhao RC, Tercyak AM, Redgrave TG. 1986. Effects of cholesterol content on the metabolism of protein-free emulsion models of lipoproteins. Biochim Biophys Acta 875:247-255.
48. Rog T, Pasenkiewicz-Gierula M. 2001. Cholesterol effects on the phospholipid condensation and packing bilayer: A molecular simulation study. FEBS Lett 502:68-71.
49. Hyslop PA, Morel B, Sauerheber RD. 1990. Organization and interaction of cholesterol and phosphatidylcholine in model bilayer-membrane. Biochemistry 29:1025-1038.
50. Dufourc EJ, Parish EJ, Chitrakorn S, Smith ICP. 1984. Structural and dynamical details of cholesterol-lipid interaction as revealed by deuterium NMR. Biochemistry 23:6062-6071.
51. Saito H, Tanaka M, Okamura E, Kimura T, Nakahara M, Handa T. 2001. Interactions of phosphatidylcholine surface monolayers with triglyceride cores and enhanced ApoA-1 binding in lipid emulsions. Langmuir 17:2528-2532.
52. Hang C, Mason JT. 1978. Geometric packing constraints in egg phosphatidylcholine vesicles. Proc Natl Acad Sci USA 75:308-310.